Oncology
Omar Nadeem, M.D.
Senior Physician, Assistant Professor of Medicine at Harvard Medical School
Boston, MA
Dr. Omar Nadeem is a medical oncologist specializing in hematologic malignancies, with a primary focus on multiple myeloma and precursor plasma cell disorders at the Dana-Farber Cancer Institute in Boston, Massachusetts. He treats patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma, relapsed and refractory multiple myeloma, and high-risk smoldering myeloma. As Clinical Director of the Myeloma Immune Effector Cell Therapy Program and the Center for
17+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (ABIM), 2012
- Hematology (ABIM), 2015
- Medical Oncology (ABIM), 2015
Education & Training
- Ross University School of Medicine — M.D., 2009
- Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital — Residency, Internal Medicine, 2009-2012
- Brown University / Warren Alpert Medical School — Fellowship, Hematology and Medical Oncology, 2012-2015
Clinical Focus
Subspecialties
Medical Oncology
Conditions & Treatments
Multiple MyelomaCAR-T Cell TherapyImmunotherapyClinical Trials & Drug Development
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
17+ years in practice